Diprivan
Product Images NDC 52584-269

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diprivan (NDC 52584-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by General Injectables & Vaccines, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart1.jpg (Chart1)

A line graph depicting plasma propofol concentration (mcg/mL) over time (minutes) after the end of infusion, showing curves for 1 hour, 10 hour, and 10 day infusion durations, with annotations for target plasma concentration and awakening point.*

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure diagram showing the molecular formula C12H18O and molecular weight 178.27, with a benzene ring bearing two isopropyl groups and one hydroxyl group, consistent with the structure of propofol, the active ingredient in Diprivan.*

FDA Label Image

Label1.jpg (Label1)

Diprivan 1% Injection Emulsion labeled as propofol, injectable emulsion with a concentration of 10 mg/ml in a 50 ml vial. The label includes storage instructions, manufacturer information (Merrxis Pharmaceutical Products), and notes that it is for intravenous use only. The label is marked with product NDC 52584-269, along with lot, expiration, and serial number placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.